Track: Cancer Cell Biology & Genetics

Cancer Cell Biology & Genetics

The COVID-19 pandemic has had a significant impact on cancer cell biology and genetics research, introducing new challenges and shifting research priorities. Disruptions in laboratory operations and reduced access to resources affected the progression of studies focused on understanding the molecular mechanisms of cancer. These interruptions have delayed the identification of new genetic markers and hindered the development of targeted therapies, impacting the overall pace of progress in cancer genomics.

Genetic Mutations and Cancer:
Explore the role of genetic mutations in cancer development, progression, and treatment resistance. Genetic Mutations and Cancer sub-session will cover the latest research on tumor genetics, key mutations linked to different cancer types, and how understanding these changes aids personalized treatment strategies.

Cell Cycle Dysregulation:
Understand how cell cycle dysregulation contributes to cancer development and progression. This sub-session will cover the molecular mechanisms behind cell cycle checkpoints, key regulatory proteins, and their role in tumor growth, as well as potential therapeutic targets for cancer treatment.

Apoptosis and Resistance to Cell Death:
Explore the intricate mechanisms of apoptosis, the programmed cell death essential for cellular homeostasis, and delve into how resistance to this process fuels cancer progression, shaping therapeutic challenges and innovative treatment strategies.

Tumor Microenvironment:
Delve into the complex interactions within the tumor microenvironment and their impact on cancer progression and treatment response. Tumor Microenvironment sub-session will explore key components such as immune cells, stromal elements, and signaling pathways, highlighting therapeutic approaches to target this environment.

Cancer Stem Cells:
Examine the role of cancer stem cells in tumor initiation, progression, and resistance to treatment. This sub-session will cover their unique properties, signaling pathways, and potential therapeutic strategies aimed at targeting these cells to improve treatment efficacy and prevent relapse.